drugset / Trial / NCT04308863

Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

NCT04308863

Phase 2 Completed 30 enrolled Nourhan M.Aly Alexandria University · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to evaluate the clinical and radiographic outcomes of Chitosan scaffold and Mineral trioxide aggregate (MTA) when used as pulpotomy agents in mature permanent teeth with irreversible pulpitis.

Timeline

Start
2018-11-15
Primary completion
2020-10-30
Completion
2020-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Chitosan scaffold Unknown
Subject Mineral Trioxide Aggregate Other / unclassified

Indications